Ira-Ida Skvortsova

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2026
The Impact of the Antidiabetic Agent Sitagliptin on the Radiation Response of Breast Carcinoma Cells with Different Metastatic Capacities.

|Jan 28, 2026
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.

Taraneh Sadat Zavvar, Giulia Santo, Leonhard Gruber

|Jan 21, 2023
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.

Dragana Savic, Teresa Bernadette Steinbichler, Julia Ingruber

|Jul 02, 2021
Cancer Stem Cells: What Do We Know about Them?

Ira Skvortsova

|Apr 03, 2021
KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.

Julia Ingruber, Dragana Savic, Teresa Bernadette Steinbichler

|Jul 08, 2020
Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer.

T B Steinbichler, J Dudas, J Ingruber

Pageof 2

Frequent Collaborators

3 joint publications

József Dudás

3 joint publications

Dragana Savic

1 joint publications

D Dejaco

1 joint publications

Taraneh Sadat Zavvar